Skip to Main Content

Author Details

Ravindra Majeti
Stanford University School of Medicine
1998
142
61
PMIDPaper TitleJournal TitlePublished Year
36260702An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.Blood Adv2023
38009738Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis.J Vis Exp2023
37704469Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).Blood Rev2023
37847741Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.Blood Cancer Discov2023
37790561AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.bioRxiv2023
37581927RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition.J Clin Invest2023
37986825Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity.Res Sq2023
37873452Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia.bioRxiv2023
38091010IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation.Blood Cancer Discov2023
36971438Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells.J Vis Exp2023
37067914Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.Blood Cancer Discov2023
36856575Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.Cancer Discov2023
36934059Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).Blood Rev2023
36897988MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.Proc Natl Acad Sci U S A2023
36355448Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.Cancer Discov2023
35926108Single-cell genomics in AML: extending the frontiers of AML research.Blood2023
35027753Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.Nat Med2022
35551192Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
35840577Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
35763671Reengineering Ponatinib to Minimize Cardiovascular Toxicity.Cancer Res2022
35532363The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.Blood Cancer Discov2022
35817829Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.Nat Cancer2022
36266326Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.Leukemia2022
36218325TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions.Cancer Discov2022
35177627CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors.Nat Commun2022
35084991Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells.Annu Rev Med2022
33473139The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells.Nat Commun2021
33737751Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells.Nat Med2021
34903734Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia.Nat Commun2021
34407958Clonal Hematopoiesis: From Mechanisms to Clinical Intervention.Cancer Discov2021
34778803NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.Blood Cancer Discov2021
34568834Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia.Blood Cancer Discov2021
33473210Restoring metabolism of myeloid cells reverses cognitive decline in ageing.Nature2021
32427583Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy.JCI Insight2020
31895700Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2.J Clin Invest2020
32038992Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.Front Oncol2020
31760071The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.J Hepatol2020
33136125CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products.Blood Adv2020
33157042Targeting LSCs: Peeling Back the Curtain on the Metabolic Complexities of AML.Cell Stem Cell2020
33123685Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.Nat Cancer2020
32150611Single-cell mutational profiling enhances the clinical evaluation of AML MRD.Blood Adv2020
32114880A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.Epigenetics2020
32543932Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience.Leuk Lymphoma2020
32269167IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia.Sci Transl Med2020
30659850Induced pluripotent stem cell modeling of malignant hematopoiesis.Exp Hematol2019
31874780Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion.Exp Hematol2019
31727951Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index.Sci Rep2019
32704085Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells.Gene Ther2019
30811285First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.J Clin Oncol2019
30889374No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AML.Cancer Cell2019
  • 1 - 50 of 142

Recommended Authors

The Broad Institute of MIT and Harvard
Career Start Year 2010
Number of shared co-authors 5
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 4
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 5
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 17
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 15
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 5
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 9
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 10
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 14
University of Washington
Career Start Year 2002
Number of shared co-authors 2
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 7
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1998
Number of shared co-authors 5
McGill University
Career Start Year 1996
Number of shared co-authors 2
University of Cambridge
Career Start Year 1996
Number of shared co-authors 7
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 7
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 9
The University of Chicago
Career Start Year 1994
Number of shared co-authors 15
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 9
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 12
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 8
Boston Children's Hospital
Career Start Year 1990
Number of shared co-authors 9
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 1
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 6

Collaborators

Gladstone Institute of Neurological Disease
Co-authored papers 16
Stanford Center for Biomedical Informatics Research, Stanford University
Co-authored papers 12
Cancer Institute, Stanford University School of Medicine
Co-authored papers 11
Institute of Space and Astronautical Science
Co-authored papers 8
AbbVie Inc.
Co-authored papers 8
University of California san francisco
Co-authored papers 7
Ulster University
Co-authored papers 7
Center for Personal Dynamic Regulomes, Stanford University
Co-authored papers 7
Stanford University
Co-authored papers 7
NYU Robert I. Grossman School of Medicine
Co-authored papers 6
Co-authored papers 6
Stanford University School of Medicine
Co-authored papers 4
Moores Cancer Center, university of california san diego
Co-authored papers 4
Smilow Cancer Center, Yale University School of Medicine
Co-authored papers 4
Novartis Institutes for BioMedical Research
Co-authored papers 4
and Blood Institute, National Institutes of Health
Co-authored papers 4
Paracelsus Medical University
Co-authored papers 4
Co-authored papers 4
The Ohio State University
Co-authored papers 4
Stanford University
Co-authored papers 3
Harvard University, Broad Institute of MIT and Harvard
Co-authored papers 3
British Columbia Cancer Research Centre
Co-authored papers 3
Memorial Sloan Kettering Cancer Center (MSKCC)
Co-authored papers 2
Co-authored papers 2
Cell Therapy Institute, Paracelsus Medical University (PMU)
Co-authored papers 2
Adelaide Medical School, University of Adelaide
Co-authored papers 2
Department of Pediatrics Stanford University Stanford California USA.
Co-authored papers 2
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Lewis Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers 2
Advanced Research Institute, Tokyo Medical and Dental University
Co-authored papers 2